Literature DB >> 557069

Antibodies against human lymphokines: I. Methods for induction of antibodies capable of neutralizing stable (alpha) and unstable (beta) lymphotoxins released in vitro by activated human lymphocytes.

J E Lewis, C E Carmack, R Yamamoto, G A Granger.   

Abstract

Various methods were employed to induce antibodies in rabbits that were capable of neutralizing different families of lymphotoxins (LT). Both stable (alpha-LT) and unstable (beta-LT) molecules, released by activated human lymphocytes in vitro, were neutralized. The different LT families were first separated into their respective groups by physical-chemical methods. Immunization with small quantities of antigen yielded a high percentage of responder animals. Techniques were developed for eliciting alpha-LT antibodies using as little as 2--3 ml of a cell-free supernatant. The situation was more difficult, however, when the unstable beta-LT molecules were employed as antigens. We found that because of the low concentration and lability of beta-LT in supernatants, the immunizing dose had to be: a) handled rapidly, b) larger than that used with the alpha-LT, and c) injected at closer intervals and over a longer immunization protocol. Physical-chemical studies supperted the concept that the LT-neutralizing activity in the immune serum was immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557069     DOI: 10.1016/0022-1759(77)90006-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Lymphokines: an increasing repertoire.

Authors: 
Journal:  Br Med J       Date:  1978-01-14

2.  Fractionation of human H1 subtypes and characterization of a subtype-specific antibody exhibiting non-uniform nuclear staining.

Authors:  M H Parseghian; R F Clark; L J Hauser; N Dvorkin; D A Harris; B A Hamkalo
Journal:  Chromosome Res       Date:  1993-07       Impact factor: 5.239

3.  Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein.

Authors:  T Hahn; L Toker; S Budilovsky; D Aderka; Z Eshhar; D Wallach
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells.

Authors:  S Yousefi; N Vaziri; G Carandang; W Le; R Yamamoto; G Granger; J Ocariz; T Cesario
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.